Brought to you by CancerNetwork


  • Round 4 (Closed)

    Are you up-to-date on the CALGB 80405 study? How about the FLAURA study in EGFR-mutated NSCLC? What is the best first-line treatment for patients with MSI-H mCRC? All this and more await you in Round 4!

  • Round 5 (Closed)

    Congratulations on making it this far! Round 5 is not for the faint-hearted. We’ve saved our most difficult questions for this final challenge. Do you have what it takes to be the champion?

Join the CancerNetwork community